
Smith & Nephew
Specializing in orthopaedics, sports medicine, and wound care.
- Healthcare
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 Valuation: €0.0 0.3x EV/EBITDA | round | |
* | $204k | Post IPO Equity | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 14 % | - | 6 % | 5 % | 6 % | 5 % | 5 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 22 % | 18 % | 21 % | 25 % | 26 % | 27 % | 28 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 10 % | 4 % | 5 % | 7 % | 11 % | 12 % | 13 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 7 % | 7 % | 5 % | 5 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Smith & Nephew is a global medical technology company that designs and manufactures advanced medical devices and solutions. The company operates in the orthopaedics, sports medicine, and advanced wound care markets, serving healthcare professionals and patients worldwide. Its business model focuses on developing innovative products that improve patient outcomes and streamline medical procedures. Smith & Nephew generates revenue through the sale of its medical devices and related services, targeting hospitals, clinics, and healthcare providers. The company's portfolio includes knee repair solutions, single-use negative pressure wound therapy systems, and extremity orthopaedics products. By collaborating with organizations like Hall of Fame Health, Smith & Nephew aims to enhance wellness and healthcare delivery.
Keywords: medical technology, orthopaedics, sports medicine, wound care, knee repair, negative pressure therapy, extremity orthopaedics, healthcare innovation, patient outcomes, medical devices.
Tech stack
Investments by Smith & Nephew
Edit






